Due to their propensity to ‘poison’ the immune system with potentially autoreactive CD8+ and CD4+ T cells [217], thymomas are exceptionally risky targets for immune checkpoint inhibitors, since they can unleash severe if not fatal autoreactivities particularly focused on skeletal and cardiac muscle [228]. This evidence concerns the gene CD8A and thymoma.